Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

Tesla Inc. could collect more than €1 billion ($1 billion) in compensation from rival automakers that need help meeting ...

Investing.com -- Nvidia (NASDAQ: NVDA ), Microsoft (NASDAQ: MSFT ), and OpenAI are the key AI beneficiaries, UBS analysts said, citing results of its latest enterprise AI survey. The survey, which ...

The Swiss bank expects the city’s benchmark index to rise above 20,000 by year-end, implying a gain of 3.7 per cent from ...

More Chinese regions are cutting electricity prices to help out their embattled industries, which is likely to worsen the squeeze on profits at power suppliers.  The richest coastal provinces have ...

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...

Shares of Paytm parent One97 Communications slipped nearly 9% to INR 895.25 apiece during the intraday trading on the BSE ...

Fintel reports that on January 7, 2025, UBS upgraded their outlook for Bank of America Corporation - Preferred Stock ...

Shares of Paytm parent One97 Communications slipped nearly 9% to INR 895.25 apiece during the intraday trading on the ...

In a report released today, Timothy Arcuri from UBS maintained a Buy rating on Nvidia (NVDA – Research Report), with a price target of $185.00.